MELAS is a dubious disease in the field of the nervous system, with complex clinical outcomes and often involving multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of MELAS requires a combination of clinical outcomes, imaging checks, laboratory tests and pathological activation.
The platform can help align national and international experts with teams to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many of the neural system diseases that have previously been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of MELAS. The platform serves a team of internationally authoritative experts at home and abroad in the field of China's International Medical Service System for Neurosystem Matching, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.